2018
DOI: 10.3892/etm.2018.6941
|View full text |Cite
|
Sign up to set email alerts
|

Expression of TLR4 gene is downregulated in acquired immune deficiency syndrome‑associated Kaposi's sarcoma

Abstract: The present study investigated the expression of Toll-like receptor 4 (TLR4) and proteins involved in its associated signaling pathways in patients with classic Kaposi's sarcoma (KS) and acquired immune deficiency syndrome (AIDS)-associated KS (AIDS-KS) in Xinjiang Autonomous Region of China. A total of 35 patients with KS were enrolled in the present study between May 2011 and July 2013, including 26 cases of AIDS-KS and 9 cases of classic KS. Another 10 healthy subjects of the Uygur ethnic group were include… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 31 publications
0
1
0
Order By: Relevance
“…The continual engagement of TLRs could lead to secondary immunosuppression to neutralize chronic proinflammatory responses and eventually favor HIV immunopathogenesis. The differential expression of TLRs in different pathological conditions of HIV/simian immunodeficiency virus (SIV) infection has been reported [ 24 , 25 ]. The trans-membrane domain of the HIV envelope directly interacts with TLR2 and attenuates TNF-α, IL-6, and MCP-1 secretions of macrophages in in vivo and in vitro models [ 26 ].…”
Section: Introductionmentioning
confidence: 99%
“…The continual engagement of TLRs could lead to secondary immunosuppression to neutralize chronic proinflammatory responses and eventually favor HIV immunopathogenesis. The differential expression of TLRs in different pathological conditions of HIV/simian immunodeficiency virus (SIV) infection has been reported [ 24 , 25 ]. The trans-membrane domain of the HIV envelope directly interacts with TLR2 and attenuates TNF-α, IL-6, and MCP-1 secretions of macrophages in in vivo and in vitro models [ 26 ].…”
Section: Introductionmentioning
confidence: 99%